METHOD AND PHARMACEUTICAL COMPOSITIONS FOR RELIABLE ACHIEVEMENT OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM Russian patent published in 2009 - IPC A61K31/56 A61P15/00 A61P15/16 

Abstract RU 2354381 C2

FIELD: pharmacology.

SUBSTANCE: claimed invention relates to field of pharmacology, as well as to field of therapeutic application of hormones in substitutive hormonal therapy of men and male contraception. Claimed composition for intramuscular injection contains testosterone ester, which is selected from group of esters, including linear and branched nonanoates, decanoates, undecanoates, dodecanoates, tridecanoates, tetradecanoates and pentadecanoates; and carrier, containing castor oil in 25-45 vol.% concentration and co-solvent. After intramuscular injection composition ensures reliable physiologically acceptable levels of testosterone in serum during long period of time. This allows to apply them in substitutive hormonal therapy and male contraception without carrying out accompanying monitoring of testosterone levels in serum by attending doctor. Also described is pharmaceutical composition containing 100 mg of testosterone undecanatoate in carrier medium, which consists of castor oil and benzyl benzoate with ratio 1:1.7 of volume.

EFFECT: use of castor oil in composition in said amount ensures obtaining product with sufficient stability, i.e. expiration date.

17 cl, 4 ex, 2 tbl, 1 dwg

Similar patents RU2354381C2

Title Year Author Number
ORAL PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE ESTERS AND METHOD FOR TESTOSTERONE SHORTAGE TREATMENT WITH THEIR USE 2010
  • Dudlej Robert E.
  • Konstantinides Panajotis P.
RU2642244C2
STABLE PHARMACEUTICAL COMPOSITION CONTAINING TESTOSTERONE UNDECANOATE 2019
  • Ahn, Byoung Ki
  • Park, So Hyun
RU2777534C1
LONG-CHAIN LIPOSBALANCED ESTERS OF TESTOSTERONE FOR ORAL DELIVERY 2014
  • Nachaegari Satish Kumar
  • Giliyar Chandrashekar
  • Patel Radzh
  • Nachiappan Chidambaram
  • Venkateshvaran Srinivansan
  • Patel Makhesh V.
RU2722592C2
COMPOSITION COMPRISING TESTOSTERONE UNDECANOATE AND CASTOR OIL 2000
  • Nejs De Khenrik
  • Chandler S'Juzn
  • Perri Ehlizabet Ehnn
  • Ferdinando Dzhozefin Dzhoan Kristin
RU2246296C2
USE OF NOVEL ETHONOGESTREL ESTERS 2003
  • De Nejs Khenrik
  • Van Der Vort Khendrikus Adrianus Antonius
  • Lejsen Dirk
  • Grotenkhejs Arej Jan
  • Van Der Lou Jap
RU2322986C2
CONTRACEPTIVE INJECTION OF OIL SOLUTION INJECTED INDEPENDENTLY 2003
  • De Nejs Khenrik
  • Van Der Vort Khendrikus Adrianus Antonius
  • Lejsen Dirk
RU2328289C2
APPLICATION OF AROMATASE INHIBITOR FOR TREATMENT OF HYPOGONADISM AND RELATED DISEASES 2012
  • Tejlor Enn
  • Klikstejn Llojd B.
RU2628808C2
COMPOUND (α)-7-METHYL-17-[(1-OXOUNDECYL)OXY]-ESTR-4-ENE-3-ONE, PHARMACEUTICAL COMPOSITION, SET FOR MALE CONTRACEPTION 1999
  • Lejsen Dirk
  • Van Der Vort Khendrikus Adrianus Antonius
RU2216546C2
STABLE COMPOUNDS OF UNDECANOATE TESTOSTERONE 2015
  • Schoonus-Gerritsma, Gerritdina G.
RU2708238C2
ABIRATERONE PRODRUGS 2020
  • Sharp Mettyu Dzh.
  • Mur Uilyam R.
RU2822219C2

RU 2 354 381 C2

Authors

Khjubler Doris

Frikke Zabine

Ingverzen Jan-Peter

Kunts Vil'Khel'M

Dates

2009-05-10Published

2004-03-15Filed